ArticleRevista de saude publica2026
BrDMrisc - Online Brazilian Risk Score for Incident Type 2 Diabetes - ELSA-Brasil Cohort.
Article in Revista de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Staging intermediate hyperglycaemia for type 2 diabetes prevention: the ELSA-Brasil study.Diabetologia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe the Brazilian Diabetes Risk Score (BrDMrisc), an online calculator for estimating the risk of developing diabetes in 10 years, comparing it to other commonly used screening approaches to identify high-risk of future diabetes.
methodsBrDMrisc is derived from 7.4-year follow-up data from ELSA-Brasil, a contemporary Brazilian cohort. Risk functions to predict future diabetes were based on socioeconomic, lifestyle, clinical, and laboratory variables, many of which are incorporated as continuous variables on a training sample including half of the analyzed cohort. We used ELSA-Brasil participant baseline data and incident diabetes cases detected during follow-up on the other half to compare the predictive capacity of BrDMrisc against traditional pre-diabetes screening strategies.
resultsBrDMrisc's 27 risk functions offer versatility to the online app, enabling estimates based on differing combinations of clinical and laboratory findings, which present more favorable diagnostic properties than other recommended approaches. For example, the BrDMrisc function based on clinical data plus fasting glucose, when compared with detection using solely the presence of impaired fasting glucose (≥ 100 mg/dL), identified a more manageable fraction (20.0% versus 40.6%) of the population as high risk, with those identified as presenting a two-fold risk of developing diabetes (28.5% versus 17.1%).
conclusionsBrDMrisc diabetes risk calculator, based on data from a contemporary Brazilian cohort, is readily available online, versatile, and presents generally more favorable diagnostic properties than other commonly used screening strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.